The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease
Journal of Vascular Surgery · 2024
DOI: 10.1016/j.jvs.2024.03.001 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Chen Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peripheral Vascular Intervention, Gansu Provincial Hospital of TCM, Lanzhou, China. Hauptthemen laut MEDLINE: Popliteal Artery, Femoral Artery, Cilostazol, Tetrazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Gansu Provincial Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Peripheral Vascular Intervention, Gansu Provincial Hospital of TCM, Lanzhou, China.
- Department of Ultrasound Medical Imaging, Gansu Provincial Hospital of TCM, Lanzhou, China.
Förderung
- Gansu Provincial Natural Science Foundation
Zitieren
APA
Wang, C., Du, Z., & Zhang, M. (2024). The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.03.001
Vancouver
Wang C, Du Z, Zhang M. The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.03.001
BibTeX
@article{Wang2024,
author = {Wang, Chen and Du, Zizhong and Zhang, Mingxing},
title = {The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease},
journal = {Journal of Vascular Surgery},
year = {2024},
doi = {10.1016/j.jvs.2024.03.001}
}
EUVIMED